Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Stigmasterol sensitizes endometrial cancer cells to chemotherapy by repressing Nrf2 signal pathway

6 Oct 2020

Abstract excerpt

BACKGROUND: Chemoresistance reduces the 5-year survival rate of endometrial cancer patient, which is the current major obstacle for cancer therapy. Increasing evidence state that Nrf2 contributes to chemoresistance in several kinds of cancer. However, its role in endometrial cancer cells remains unclarified. METHODS: Immunohistochemistry staining was used to detect the expression of Nrf2 in normal patient and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genomics, phytochemicals, and oxidative stress
Share to Sirtuins and Resveratrol in Medicine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33041661
DOI: 10.1186/s12935-020-01470-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Stigmasterol sensitizes endometrial cancer cells to chemotherapy by repressing Nrf2 signal pathwayPMID 33041661Read ↗

Metapristone (RU486-derivative) inhibits endometrial cancer cell progress through regulating miR-492/Klf5/Nrf1 axisSemantic proximity Read ↗

Nrf2, the master redox switch: the Achilles' heel of ovarian cancer?Semantic proximity Read ↗

Erianin facilitates pyroptosis in endometrial cancer via targeting m6A reader YTHDF1Semantic proximity Read ↗

Role of NRF2 cascade in determining the differential response of cervical cancer cells to anticancer drugs- an in vitro studySemantic proximity Read ↗

Targeting RNF8 Effectively Reverse Cisplatin and Doxorubicin Resistance in Endometrial CancerSemantic proximity Read ↗

Resveratrol activates MAPK/ERK pathway to regulate oestrogen metabolism in type I endometrial cancerSemantic proximity Read ↗

Small Molecule Screen Identifies Pyrimethamine as an Inhibitor of NRF2-driven Esophageal HyperplasiaSemantic proximity Read ↗

hTERT Promotes CRC Proliferation and Migration by Recruiting YBX1 to Increase NRF2 ExpressionSemantic proximity Read ↗

Brusatol Sensitizes Endometrial Hyperplasia and Cancer to Progestin by Suppressing Nrf2-Tet1-AKR1C1-Mediated Progestin MetabolismSemantic proximity Read ↗

Interaction of ERα and NRF2 Impacts Survival in Ovarian Cancer PatientsSemantic proximity Read ↗

Focusing on Keap1, IKKβ, and Bcl2 proteins: predicted targets of stigmasterol in neurodegenerationSemantic proximity Read ↗

Endometrial stem cells alleviate cisplatin-induced ferroptosis of granulosa cells by regulating Nrf2 expressionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.